creatine phosphokinase – Communicable Diseases Research

Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Article

Published on 2022-12-012022-11-15
Journal: Emerging Microbes & Infections
[Category] COVID19(2023년), SARS, 변종, 비임상, 진단, 치료기술, 치료제,

Evaluating the Factors Affecting COVID-19 Patients’ Mortality in Arak in 2020

Article

Published on 2022-09-162022-11-15
Journal: Canadian Respiratory Journal
[Category] SARS, 치료제,

[키워드] Acute kidney injury acute respiratory distress Admission affected age AKI Antibiotic therapy Antiviral arrhythmia blood pressure C-reactive protein cardiovascular disease cause Complication coronavirus disease Course COVID-19 creatine phosphokinase creatinine D-dimer death Diabetes Mellitus disease Disease progression elevated Evaluating expired Factor ferritin hemoglobin Hospitalization intensive care International investigated Laboratory lactate dehydrogenase liver enzyme Lung disease Lymphocytes Mortality Myocardial infarction normalized occur onset of symptom oxygen saturation pandemic patients Prevent Prothrombin time recovered patient risk factor Risk factors Sepsis syndrome Tachycardia tachypnea the disease two group underlying diseases White blood cell
[DOI] 10.1155/2022/9594931 PMC 바로가기

Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination

증례 보고서: ChAdOx1 nCoV-19 백신 접종 후 심각한 횡문근 융해증 및 다기관 부전

Case Reports

Published on 2022-03-172022-09-12
Journal: Frontiers in Immunology
[Category] MERS, SARS, 진단,

[키워드] accelerated Anakinra assumption biologic Bone marrow Case report ChAdOx1 ChAdOx1 nCoV-19 characterized creatine phosphokinase cytokine Cytokine storm Deterioration dramatic increase drug eculizumab failure first dose had no healthy hypoglycemia immunosuppressive Infection inflammatory markers kidney liver lung multi organ failure nine occur occurred patient death patients with SARS-CoV-2 PCT physician procalcitonin rapid increase reported resulting rhabdomyolysis Risk factors SARS-CoV-2 SARS-CoV2 Shock Skeletal muscle Steroids therapy Treatment vaccination vaccination. vaccine administration
[DOI] 10.3389/fimmu.2022.845496 PMC 바로가기 [Article Type] Case Reports

Criteria and potential predictors of severity in patients with COVID-19

Research

Published on 2022-02-192022-10-31
Journal: The Egyptian Journal of Bronchology
[Category] COVID-19,

The predictive power of serum vitamin D for poor outcomes in COVID‐19 patients

Original Research

Published on 2021-09-192022-10-31
Journal: Food Science & Nutrition
[Category] COVID-19,

[키워드] adjusted Admission age age and gender association C‐reactive protein Characteristics clinical symptom complete blood count Concentration confounder Coronavirus infections COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 creatine phosphokinase creatinine death deficiency defined erythrocyte sedimentation rate Gender hospital Hospitalization Hospitalized hospitalized patient ICU identify immune response Invasive mechanical ventilation Iran lactate dehydrogenase less Logistic regression males Mortality outcome parameter Patient Physicians predictive power Prevalence Prophylactic retrospective cohort study risk risk of death SARS‐CoV‐2 serum 25 serum vitamin D statistical model statistically significant Tehran tested the mean Treatment protocol viral infections Vitamin D vitamin D deficiency vitamin D supplement were recorded
[DOI] 10.1002/fsn3.2591 PMC 바로가기 [Article Type] Original Research

SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study

소아의 SARS-CoV-2 RNAaemia:이란 의뢰 병원 기반 연구

Article

Published on 2021-09-012022-09-11
Journal: Journal of medical virology
[Category] SARS, 바이오마커, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults association Blood coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 creatine creatine phosphokinase disease severity evaluate Fever groups individual Laboratory laboratory findings Laboratory tests Magnesium marker Mortality nasopharyngeal swabs patients patients with SARS-CoV-2 Pediatric patient Pediatric patients pediatrics positive predict reported respiratory RNA RNAaemia SARS-CoV-2 SARS-CoV-2 RNA detection severe acute respiratory syndrome Coronavirus severe COVID-19 severity Severity. significant difference significant differences Symptom tachypnea the disease the patient the SARS-CoV-2 Viral Viral RNA vomiting
[DOI] 10.1002/jmv.27065 PMC 바로가기 [Article Type] Article

Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an Emergency Medicine Unit

Observational Study

Published on 2021-09-012022-10-05
Journal: International journal of clinical practice
[Category] SARS, 임상,

Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-10-302022-10-29
Journal: Trials
[Category] Coronavirus, MERS, SARS,

[키워드] adjuvant Administered Adverse age alanine aminotransferase All study participant allergy approved ARDS Aspartate transaminase Aspirin atorvastatin benefit bleeding block randomization Breastfeeding C-reactive protein characterized clinical Clinical deterioration Clinical improvement Clinical outcome Coagulopathy collected data computer-generated conducted confirmed case control group COVID-19 COVID-19 patient COVID-19 patients CPK creatine phosphokinase Critical derivative discharge dissemination dose drug drug interaction ECMO Effect element Endotracheal intubation enrolment ethical committee evaluated examined excluded exclusion criteria Final Hepatitis HIV Hospital admission hospital discharge hospitalisation ICMR ICU admission in-hospital mortality include Inclusion India infected with SARS-CoV-2 Inflammatory marker interim analysis liver management mechanical ventilation Medical Science medication Mortality myalgia National Cancer Institute New Non-invasive number objective Open-label Other outbreak outcome outcomes pandemic parallel-group participant Patient patients Platelet Pregnancy Primary outcome progression Protease inhibitor protease inhibitors protocol randomised Randomised control trial randomised controlled trial randomize Randomized receiving recruited recruitment reference Registered registry renal replacement therapy respiratory RT-PCR Sample size SARS-CoV-2 SARS-COV-2 infection secondary outcome serum Shock statin status study period Study protocol supplementary material symptom onset Tablet therapy Treatment protocol Trial troponin usual care website WHO written consent written Informed Consent
[DOI] 10.1186/s13063-020-04840-y PMC 바로가기 [Article Type] Letter

Rhabdomyolysis in a Patient With Coronavirus Disease 2019

Internal Medicine

Published on 2020-07-012022-10-31
Journal: Cureus
[Category] COVID-19,